FIELD: medicine.
SUBSTANCE: invention can be used to treat certain autoimmune inflammation syndromes. A method of treating an autoimmune inflammatory syndrome selected from the group consisting of hyper-IgD syndrome (HIDS), Schnitzler's syndrome and adult-onset Still's syndrome (AOSD) involves administering to a patient in need thereof an effective amount of a drug containing an antibody, wherein the antibody is ACZ885.
EFFECT: invention provides effective treatment of these syndromes due to the destruction of interaction between IL-1β ligand and IL-1 receptor.
8 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW INDICATIONS FOR USE IN TREATING ANTIBODIES AGAINST IL-1-BETA | 2014 |
|
RU2698208C2 |
| NOVEL APPLICATION OF IL-1β COMPOUNDS | 2012 |
|
RU2571563C2 |
| NEW APPLICATION OF IL-1β COMPOUNDS | 2006 |
|
RU2468817C2 |
| HUMAN ANTIBODIES TO IL-β1 | 2001 |
|
RU2286351C2 |
| RECOMBINED ANTIBODY TO HUMAN INTERLEUKIN 1β | 2001 |
|
RU2264413C2 |
| FORMULATIONS CONTAINING ANTIBODIES | 2009 |
|
RU2745601C2 |
| ANTIBODIES RAISED TO HUMAN MCP-1 | 2001 |
|
RU2314316C2 |
| METHOD FOR OBTAINING BI-SPECIFIC ANTIBODIES, BI-SPECIFIC ANTIBODIES AND THERAPEUTIC APPLICATION OF SUCH ANTIBODIES | 2018 |
|
RU2795240C2 |
| METHODS OF TREATING PATHOLOGICAL CONDITIONS WITH ANTIBODIES WHICH BIND TO THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R) | 2013 |
|
RU2718751C2 |
| IL-18-BINDING PROTEIN (IL-18BP) AND ANTIBODIES IN INFLAMMATORY DISEASES | 2016 |
|
RU2755691C2 |
